The blepharoplasty market has seen considerable growth due to a variety of factors.
• The size of the blepharoplasty industry has seen a robust growth recently. Its value is expected to rise from $4.2 billion in 2024 to $4.55 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%.
The increases during the historical period can be credited to factors such as aesthetic inclinations and beauty norms, the aging demographic, heightened consciousness and acceptance, along with the influence of media and celebrities.
The blepharoplasty market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of blepharoplasty is anticipated to witness significant growth in the coming years, reaching $6.28 billion by 2029, at a compound annual growth rate (CAGR) of 8.4%.
This expansion in the forecasted period can be credited to factors such as an increase in disposable income, social and cultural aspects, procedure customization, medical tourism, and better accessibility. The projected period will also see major trends like a shift towards natural and youthful outcomes, the incorporation of technology for accuracy and safety, the rise of combination procedures, heightened demand for ethnic-specific blepharoplasty, and the expanding role of non-surgical alternatives.
The rise in desire for cosmetic surgeries is projected to drive the expansion of the blepharoplasty market. Cosmetic surgeries, which are medical procedures designed to modify or enhance one's appearance for aesthetics, help people improve their eyelids' look and handle problems with the upper eyelids like excess skin, drooping skin and fatty deposits causing a bloated look. For example, the International Society of Aesthetic Plastic Surgery, a US-based entity, reported that in 2022, plastic surgeons executed more than 14.9 million surgical and 18.8 million non-surgical procedures worldwide, showing an overall growth of 11.2%. Therefore, the escalating demand for cosmetic surgeries is contributing to the expansion of the home blepharoplasty market.
The blepharoplasty market covered in this report is segmented –
1) By Type: Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty, Combination Eyelid Surgery
2) By Gender: Female, Male
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centre, Other End-Users
Subsegments:
1) By Upper Eyelid Blepharoplasty: Traditional Upper Eyelid Surgery, Laser Upper Eyelid Surgery
2) By Lower Eyelid Blepharoplasty: Transconjunctival Lower Eyelid Surgery, Traditional Lower Eyelid Surgery
3) By Combination Eyelid Surgery: Upper And Lower Eyelid Surgery Together, Eyelid Surgery With Other Facial Procedures
Key players in the blepharoplasty market are investing in the development of cutting-edge technologies like plasma technology to establish a strong market foothold. Plasma technology involves using ionized gases, or plasmas, in special medical devices for non-invasive skin rejuvenation and tightening around the eyelids and other facial regions. A case in point is the launch of the latest-generation Renuvion generator, the Apyx One Console, by Apyx Medical Corporation, a US advanced energy technology firm, in January 2023. The Apyx One Console is a versatile energy platform rendered for plastic and cosmetic surgery, leveraging Renuvion technology (helium plasma and radiofrequency technology), alongside monopolar and bipolar energy options. The console's features include adaptive touchscreens, procedural presets, cloud connectivity, remote upgrade abilities, gas volume monitor, and other sophisticated features that enhance cosmetic surgical procedures, including eyelid surgery.
Major companies operating in the blepharoplasty market report are:
• Zimmer Biomet Holdings Inc.
• Cynosure Technologies Pvt Ltd.
• Galderma SA
• Bausch & Lomb Incorporated.
• Allergan Inc.
• Integra LifeSciences Inc.
• Merz Pharma GmbH & Co. KGaA
• Corza Ophthalmology
• Lumenis Ltd.
• Cutera Inc.
• Stille AB
• Alma Lasers Ltd.
• Sciton Inc.
• Beaver-Visitec International Holdings Inc.
• Sklar Surgical Instruments
• Hayden Medical Inc.
• Gulmaher Surgico
• Titan Medical Inc.
• Luminera Derm Ltd.
• Jedmed Instrument Company.
• Xelpov Surgical
• Surgitrac Instruments UK Limited
• Grand Aespio Inc.
• Surgical Holdings
• Surgipro Inc.
• LightScalpel Inc.
• SPIRAL Surgical Co.
• Carnegie Surgical LLC.
• Ambler Surgical LLC
North America was the largest region in the blepharoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blepharoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa